Next Article in Journal
Effect of Green Tea Supplementation on Antioxidant Status in Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Next Article in Special Issue
Phytochemicals from the Cocoa Shell Modulate Mitochondrial Function, Lipid and Glucose Metabolism in Hepatocytes via Activation of FGF21/ERK, AKT, and mTOR Pathways
Previous Article in Journal
2-Hydroxymelatonin, Rather Than Melatonin, Is Responsible for RBOH-Dependent Reactive Oxygen Species Production Leading to Premature Senescence in Plants
Previous Article in Special Issue
Antioxidant Effect of Lonicera caerulea L. in the Cardiovascular System of Obese Zucker Rats
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 10
Issue 11
10.3390/antiox10111730
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary Strawberries Improve Biomarkers of Antioxidant Status and Endothelial Function in Adults with Cardiometabolic Risks in a Randomized Controlled Crossover Trial

by
Arpita Basu
1,*,
Kenneth Izuora
2,
Nancy M. Betts
3,
Jeffrey L. Ebersole
4 and
Robert Hal Scofield
5,6
1
Department of Kinesiology and Nutrition Sciences, University of Nevada at Las Vegas, Las Vegas, NV 89154, USA
2
Section of Endocrinology, University of Nevada School of Medicine at Las Vegas, Las Vegas, NV 89154, USA
3
Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA
4
School of Dental Medicine, University of Nevada at Las Vegas, Las Vegas, NV 89154, USA
5
Section of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
6
Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
*
Author to whom correspondence should be addressed.
Antioxidants 2021, 10(11), 1730; https://doi.org/10.3390/antiox10111730
Submission received: 14 October 2021 / Revised: 26 October 2021 / Accepted: 26 October 2021 / Published: 29 October 2021
(This article belongs to the Special Issue Antioxidant Foods and Cardiometabolic Health)
Versions Notes

Abstract

:
Strawberries, a popularly consumed berry fruit, are rich in bioactive compounds with antioxidant effects. In this study, we examined the effects of two dietary achievable doses of strawberries on the antioxidant status and biomarkers of endothelial function in adults with features of metabolic syndrome and a confirmed low baseline of fruit and vegetable intake. In a 14-week randomized controlled crossover study, participants were assigned to one of three groups for four weeks separated by a one-week washout period: control powder, one serving (low dose: 13 g strawberry powder/day), or 2.5 servings (high dose: 32 g strawberry powder/day). Blood samples and health data were collected at baseline and at the end of each four-week phase of intervention. Thirty-three participants completed all three phases of the trial. Significant increases were observed in serum antioxidant capacity and superoxide dismutase activity as well as decreases in lipid peroxidation after both low and high dose strawberry phases when compared with the control phase. Significant decreases were also observed in soluble vascular cell adhesion molecule-1 and tumor necrosis factor-α with the high dose strawberry phase. These data confirm that consuming strawberries for four weeks significantly improves antioxidant status, endothelial function, and inflammation in adults with cardiometabolic risks.

1. Introduction

In recent years, accumulated evidence from several lines of research has supported the benefits of dietary berries for improving cardiometabolic risk in the adult population [1,2,3,4]. Most of these benefits have been attributed to the role of berry phytochemicals, especially the polyphenolic flavonoids and other bioactive compounds, towards minimizing oxidative stress, inflammation, and related pathological pathways underlying diabetes and vascular dysfunction [5]. Oxidative stress has been positively correlated with endothelial dysfunction [6,7], and biomarkers of endothelial dysfunction, such as adhesion and inflammation molecules, have been shown to be modulated by dietary polyphenols found in plant-based diets [8]. While epidemiological studies show an inverse association of dietary berry consumption with diabetes risk [1,2], randomized controlled trials on the effects of berries on biomarkers of antioxidant/oxidative stress status and endothelial function are lacking in adults with cardiometabolic risk factors.
Antioxidant enzymes and their cofactors, such as the concentration of glutathione, have been shown to be decreased in erythrocytes of patients with type 2 diabetes (T2D), consistent with increased susceptibility to oxidative damage and other complications [9,10]. The enzymes of the glutathione system, such as glutathione reductase and glutathione peroxidase, are also altered in diabetic vs. non-diabetic control subjects [11,12]. Among the categories of dietary phytochemicals with known antioxidant effects in humans, anthocyanins and ellagic acid present in the berries have been shown to improve antioxidant enzyme profiles. In a clinical trial in healthy volunteers (n = 57), consumption of anthocyanin-rich fruit juice caused a significant increase in superoxide dismutase (SOD) activity when compared to the placebo group [13]. In another study among patients with T2D (n = 44), ellagic acid supplementation significantly increased activities of SOD, as well as glutathione peroxidase enzymes, and increased total blood antioxidant capacity vs. the placebo group [14]. Anthocyanins and ellagic acid are the major bioactive compounds in dietary berries, especially in strawberries [15], which justifies the opportunity to examine their effects on these antioxidant biomarkers. While these results have been encouraging, the small number of such reported trials, as well as the lack of such studies conducted in adults with metabolic syndrome or prediabetes, makes it difficult to clarify the potential role of berries and their bioactive compounds on antioxidant profiles in these adults at risk. Endothelial dysfunction underlies the initiation and progression of atherosclerotic cardiovascular disease [16]. Again, very few studies have examined the role of dietary berries on biomarkers of endothelial dysfunction. In one clinical study among adults with hypercholesterolemia (n = 150), administration of purified anthocyanins significantly decreased adhesion molecules and biomarkers of inflammation vs. placebo [17]. On the other hand, in adults with cardiometabolic risk (n = 18), consumption of a wild blueberry drink decreased DNA oxidative damage but did not affect biomarkers of endothelial function and inflammation [18]. As conflicting results could arise from differences in sample size and participants’ metabolic characteristics, there is a need to examine these effects in controlled studies in adults with metabolic syndrome.
Among dietary berries, commonly consumed berries such as blueberries, cranberries, and strawberries, have shown distinct benefits in adults with metabolic syndrome [19]. Our group has previously reported the effects of functional foods such as green tea, blueberries, and strawberries on improving antioxidant profiles and biomarkers of endothelial function in adults with diabetes risk [20,21,22]. We recently reported a dose–response study in which we observed improved insulin resistance following intake of a dietary achievable dose of strawberries for four weeks in adults with obesity and above optimal blood LDL-cholesterol [23]. We are now reporting serum biomarkers of antioxidants, endothelial function, and inflammation in the same study population. We hypothesize that dietary supplementation of strawberries will improve these biomarkers in adults at risk for developing T2D and related CVD pathologies.

2. Methods

2.1. Study Design and Criteria

As previously described, this was a randomized, crossover-controlled, double-blind study for 14 weeks in which adult participants were recruited at three different campuses at the University of Nevada at Las Vegas, University of Oklahoma Health Sciences Center, and the Oklahoma State University [23]. The study was approved by the respective Institutional Review Boards (IRB number 1119274) and was registered at http://clinicaltrials.gov/. (Identifier: NCT03441620). All participants provided written informed consent. The study criteria, as previously explained, involved inclusion based on above optimal serum LDL-cholesterol and features of metabolic syndrome. Participants were excluded if they took medications for lowering lipids and glucose levels, were allergic to strawberries, and/or had chronic and acute health conditions that required medical treatment [23].

2.2. Intervention and Protocol

Participants were randomized into one of three interventions for four weeks in the crossover design with a one-week washout phase between each phase: control, one serving of strawberries, or two-and-half servings of strawberries. The strawberries were administered as freeze-dried strawberry powder (FSP). The caloric content of the control and strawberry powders ranged from 122 to 124 kcal, and the carbohydrate content ranged from 27 to 29 g daily. While the control powder did not provide bioactive compounds, the total polyphenols in one and two-and-half servings of FSP were 400 and 960 mg, respectively, and total anthocyanin content was 38 and 92 mg, respectively, as a daily dose. In addition, fiber intake ranged from 3 to 5 g for the control and strawberry interventions [23]. The participants were instructed to reconstitute the powders in plain drinking water and consume them as a beverage twice a day and at least six to eight hours apart. Health history data and blood samples were collected at baseline and at the end of each four-week phase of the study.

2.3. Biomarkers of Antioxidant Status

Serum samples collected at baseline and at the end of each four-week phase of the study were analyzed for antioxidant biomarkers. Serum catalase and glutathione peroxidase (GPX) were determined using a spectrophotometric assay based on the manufacturer’s protocol (Oxis Research, Portland, OR, USA). Glutathione reductase (GR) and superoxide dismutase (SOD) activity were measured using commercially available kits (Cayman Chemical, Ann Arbor, MI, USA). Reduced glutathione was measured as previously described by Beutler et al. [24] based on the absorbance of the yellow thiolate anion at 412 nm. Total serum antioxidant capacity was measured using the metmyoglobin assay developed by Miller et al. [25]. Serum nitrite was measured using the Griess Reagent System (Promega Corporation, Madison, WI, USA). Serum malondialdehyde (MDA) levels were measured by the method of Jain et al. [26] based on the reaction of MDA with thiobarbituric acid to produce a complex that can be determined spectrophotometrically at 532 nm. All the inter-assay CVs ranged between 3 and 7%.

2.4. Biomarkers of Endothelial Function and Inflammation

Serum adhesion molecules (soluble E-selectin [sE-Selectin], soluble P-selectin [sP-Selectin], soluble intercellular adhesion molecule-1 [sICAM-1], and soluble vascular cell adhesion molecule-1 [sVCAM-1]), as well as inflammatory analytes (interleukin [IL]-6, IL-1β, tumor necrosis factor-α), were measured using a Quantikine human immunoassay kits (R&D Systems, Minneapolis, MN, USA). All these inter-assay CVs ranged between 4 and 8%.

2.5. Statistical Analysis

Continuous variables are expressed as means ± SD and no value was detected as an outlier. We used a mixed model ANOVA to examine the main effects of treatment, time, and interactions, which were then used to analyze differences in outcomes at the end of each four-week phase of intervention. Baseline values were included as covariates for each outcome variable. Outcomes were modeled as repeated measures with the subject as a random effect and with unstructured variance for treatment/time. The sequence of intervention was included in all models to test for carry-over effects, and none were detected. As an exploratory analysis, we also used correlation methods to examine positive or inverse correlations among biomarkers of antioxidant status and inflammation. All p values were 2-tailed and main effects and interaction effects were considered if <0.05. Analyses were performed using SPSS, version 26.0 (SPSS, Armonk, NY, USA).

3. Results

As previously reported, a total of 33 adults (31 females, 2 males) completed all phases of the randomized crossover study [23]. Enrolled participants had a baseline BMI of 33 ± 3 kg/m2 (mean ± SD), 2 of the 33 were males who had a low intake of fruits and vegetables at baseline (1.0 ± 0.4, and 1.3 ± 0.2 cups/day, respectively), and were insulin resistant based on HOMA-IR (3.6 ± 1.5). Overall, BMI did not change after any phase of the interventions in the study.
As shown in Table 1, among the biomarkers of antioxidant status, serum SOD and antioxidant capacity significantly increased after the 4-week low dose as well as the high dose, strawberry phase when compared to baseline and control phases. Serum MDA significantly decreased after the 4-week low dose and high dose strawberry phases when compared to the baseline and control phases. Serum levels of glutathione showed a borderline significant increase following only the high dose strawberry phase.
As shown in Table 2, among the biomarkers of endothelial dysfunction and inflammation, both serum sVCAM-1 and TNF-α were significantly decreased after the 4-week high dose strawberry phase when compared to baseline, control, and low dose strawberry phases.
Finally, in our exploratory analyses as shown in Table 3, we observed some significant correlations among biomarkers in a model adjusted for baseline age and BMI. As expected, we observed a significant inverse correlation between glutathione and antioxidant capacity with sVCAM-1, and between SOD and TNF-α. In contrast, we observed a significant positive correlation between serum MDA, a biomarker of lipid oxidation, and TNF-α, a biomarker of inflammation.

4. Discussion

We observed some notable differences in antioxidant status and biomarkers of endothelial dysfunction and inflammation following a dietary intervention of two different doses of strawberries in adults with cardiometabolic risk in a randomized crossover study. There was a significant improvement in antioxidant status reflected by an increase in serum SOD and overall antioxidant capacity, and a concomitant decrease in lipid peroxidation following a four-week supplementation of one serving as well as two-and-a-half servings, of strawberries daily. Decreases were also observed in serum levels of the adhesion molecule, sVCAM-1, and inflammatory biomarker, TNFα, following the same dose of strawberries. To our knowledge, this is the first clinical study to identify improvements in antioxidant status following a short-term supplementation of whole strawberries in adults with habitual low consumption of fruits and vegetables, obesity, and insulin resistance.
Our findings of improved antioxidant status conform to the few reports on the role of dietary berries conducted mostly in healthy adults. Strawberry supplementation has been shown to increase plasma antioxidant capacity in healthy humans, though none of these studies reported effects on antioxidant enzymes in the participants [27,28,29]. However, a variety of other dietary bioactive rich compounds, such as curcumin and anthocyanins, have also been shown to increase antioxidant enzymes in clinical trials. In adults with metabolic syndrome, curcuminoid-piperine supplementation significantly increased serum SOD activity as well as decreased serum MDA levels [30]. Similar results showed decreases in MDA and serum SOD activity following red wine supplementation in healthy volunteers [31]. In a meta-analysis of 17 RCTs involving grape polyphenol supplementation, significant increases in antioxidant capacity and SOD activity were observed in healthy volunteers. Interestingly, no differences were noted in other antioxidant enzyme markers [32]. In another study of healthy humans, a 4-week supplementation of acai berry juice significantly increased total blood antioxidant capacity, as well as catalase and GPX activities [33]. Thus, while fruit-derived polyphenols may differentially affect each of the antioxidant enzyme as biomarkers of improved health, there is a clear gap in the knowledge of their effects in adults with cardiometabolic risks that our findings have addressed.
Our findings of decreased serum in the vascular adhesion molecule, VCAM-1, and inflammatory molecule, TNF-α, following the higher dose supplementation of strawberries in adults with cardiometabolic risks agree with our previously reported studies. These include the effects of consuming approximately four-and-half servings of strawberries for eight weeks that decreased serum VCAM-1 in adults with metabolic syndrome [34] and the effects of a similar dose of strawberries that decreased serum TNF in adults with knee osteoarthritis and cardiometabolic risk [35]. The current findings have additional clinical application as improvements were observed even at a lower dose of strawberry intake than supplements in our earlier studies. This contrasts with the administration of wild blueberry juice for seven days in adults at risk for T2D that showed no changes in glycemic control and biomarkers of inflammation or adhesion molecules [36]. In preclinical models of diet-induced atherosclerosis in mice, a combination of freeze-dried fruit and vegetable powder decreased serum TNF-α at a dose of approximating eight to nine servings/day in humans [37]. Similar decreases in inflammatory biomarkers, including interleukins and TNFα, as well as adhesion molecules, were observed in endothelial cells treated with Aronia berry extract [38]. Furthermore, Pietro et al. reported a comprehensive review of dietary polyphenols by themselves or in combination with carotenoids, as found in fruits and vegetables, to significantly reduce the expression of biomarkers of endothelial dysfunction [39]. While these combined results provide some mechanistic insight into our clinical observations, there remains an urgent need for further studies to document these effects of dietary berries in adults with prediabetes and at risk for atherosclerotic CVD. In this exploratory analysis, we observed significant inverse correlations of biomarkers of antioxidant status with VCAM-1 and TNFα, as well as a positive correlation between lipid peroxidation and TNFα in our pooled sample of all participants. Similar correlations have been reported in observational studies in adults with metabolic syndrome or T2D [40,41,42], thereby confirming the potential impact of antioxidant interventions derived from whole foods on these populations at risk for CVD.
Some limitations of this study include it being a randomized crossover study and that each phase lasted only four weeks. Longer duration studies should provide more robust outcomes. We specifically included adults not taking medications for chronic conditions such as T2D and CVD. Because of this, there are some limitations on the generalizability to the larger population since a high number of people are medicated for these conditions. Only MDA was explored as a biomarker of oxidative stress byproducts; future studies should include effects on protein oxidation products and their associated effects on the vasculature. Despite these limitations, we have reported novel data on the role of dietary achievable strawberry bioactive agents in improving systemic antioxidant status and inflammation in adults with cardiometabolic risks.

5. Conclusions

Our findings support that the dietary consumption of whole strawberries, fresh or frozen, as a source of antioxidants, can perform as active nutritional therapy for CVD and diabetes prevention and management. In addition to improving antioxidant status, strawberries also lowered the selected biomarkers of inflammation and endothelial dysfunction. These data further strengthen the evidence of the cardioprotective role of strawberries in adults with obesity and elevated cholesterol.

Author Contributions

Conceptualization, A.B.; Data curation, N.M.B.; Formal analysis, N.M.B.; Funding acquisition, A.B., N.M.B. and R.H.S.; Investigation, A.B., K.I., N.M.B. and R.H.S.; Methodology, A.B. and R.H.S.; Software, N.M.B.; Supervision, K.I.; Writing—original draft, A.B.; Writing—review & editing, A.B., K.I., J.L.E. and R.H.S. All authors have read and agreed to the published version of the manuscript.

Funding

This publication was made possible by the NIH grant U54GM104938 (Oklahoma Shared Clinical and Translational Resource), OUHSC (RHS), and the generous supply of control and freeze-dried strawberry powders from the California Strawberry Commission (Watsonville, CA, USA) (AB). Funding was also provided by the SIHS Dean’s Faculty Development Award to AB at UNLV.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the University of Nevada at Las Vegas (protocol number 1119274 and was approved in February 2018).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The datasets analyzed in the current study are not publicly available due to ethical reasons and because our participants only gave their consent for the use of their data by the original team of investigators.

Acknowledgments

We thank all our participants and their family members for their participation in our study.

Conflicts of Interest

The authors declare no conflict of interest.

Clinical Trial Registry

Clinicaltrials.gov identifier NCT03441620.

References

  1. Guo, X.; Yang, B.; Tan, J.; Jiang, J.; Li, D. Associations of dietary intakes of anthocyanins and berry fruits with risk of type 2 diabetes mellitus: A systematic review and meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 2016, 70, 1360–1367. [Google Scholar] [CrossRef] [PubMed]
  2. Wedick, N.; Pan, A.; Cassidy, A.; Rimm, E.; Sampson, L.; Rosner, B.; Willett, W.; Hu, F.; Sun, Q.; Dam, R. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. SciVee 2012, 4, 925–933. [Google Scholar] [CrossRef] [Green Version]
  3. Blacker, B.C.; Snyder, S.M.; Eggett, D.L.; Parker, T. Consumption of blueberries with a high-carbohydrate, low-fat breakfast decreases postprandial serum markers of oxidation. Br. J. Nutr. 2012, 109, 1670–1677. [Google Scholar] [CrossRef] [PubMed]
  4. Blumberg, J.B.; Basu, A.; Krueger, C.G.; Lila, M.A.; Neto, C.C.; Novotny, J.A.; Reed, J.D.; Rodriguez-Mateos, A.; Toner, C.D. Impact of Cranberries on Gut Microbiota and Cardiometabolic Health: Proceedings of the Cranberry Health Research Conference 2015. Adv. Nutr. 2016, 7, 759S–770S. [Google Scholar] [CrossRef] [PubMed]
  5. Basu, A.; Rhone, M.; Lyons, T.J. Berries: Emerging impact on cardiovascular health. Nutr. Rev. 2010, 68, 168–177. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Incalza, M.A.; D’Oria, R.; Natalicchio, A.; Perrini, S.; Laviola, L.; Giorgino, F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vasc. Pharmacol. 2018, 100, 1–19. [Google Scholar] [CrossRef] [PubMed]
  7. Odegaard, A.O.; Jacobs, D.R., Jr.; Sanchez, O.A.; Goff, D.C.; Reiner, A.P.; Gross, M.D. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc. Diabetol. 2016, 15, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Mena, M.-P.; Sacanella, E.; Vazquez-Agell, M.; Morales, M.; Fitó, M.; Escoda, R.; Serrano-Martínez, M.; Salas-Salvadó, J.; Benages, N.; Casas, R.; et al. Inhibition of circulating immune cell activation: A molecular antiinflammatory effect of the Mediterranean diet. Am. J. Clin. Nutr. 2008, 89, 248–256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Lutchmansingh, F.K.; Hsu, J.W.; Bennett, F.I.; Badaloo, A.; McFarlane-Anderson, N.; Gordon-Strachan, G.M.; Wright-Pascoe, R.A.; Jahoor, F.; Boyne, M.S. Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia. PLoS ONE 2018, 13, e0198626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Sekhar, R.V.; McKay, S.V.; Patel, S.G.; Guthikonda, A.P.; Reddy, V.T.; Balasubramanyam, A.; Jahoor, F. Glutathione Synthesis Is Diminished in Patients With Uncontrolled Diabetes and Restored by Dietary Supplementation With Cysteine and Glycine. Diabetes Care 2010, 34, 162–167. [Google Scholar] [CrossRef] [Green Version]
  11. Gawlik, K.; Naskalski, J.W.; Fedak, D.; Pawlica-Gosiewska, D.; Grudzień, U.; Dumnicka, P.; Małecki, M.T.; Solnica, B. Markers of Antioxidant Defense in Patients with Type 2 Diabetes. Oxid. Med. Cell. Longev. 2015, 2016, 2352361. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Kesavulu, M.M.; Giri, R.; Rao, B.K.; Apparao, C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab. 2000, 26, 387–392. [Google Scholar] [PubMed]
  13. Bakuradze, T.; Tausend, A.; Galan, J.; Groh, I.A.M.; Berry, D.; Tur, J.A.; Marko, D.; Richling, E. Antioxidative activity and health benefits of anthocyanin-rich fruit juice in healthy volunteers. Free Radic. Res. 2019, 53, 1045–1055. [Google Scholar] [CrossRef] [PubMed]
  14. Ghadimi, M.; Foroughi, F.; Hashemipour, S.; Nooshabadi, M.R.; Ahmadi, M.H.; Nezhad, A.B.; Haghighian, H.K. Randomized double-blind clinical trial examining the Ellagic acid effects on glycemic status, insulin resistance, antioxidant, and inflammatory factors in patients with type 2 diabetes. Phytother. Res. PTR 2021, 35, 1023–1032. [Google Scholar] [CrossRef]
  15. Basu, A.; Nguyen, A.; Betts, N.M.; Lyons, T.J. Strawberry as a functional food: An evidence-based review. Crit. Rev. Food Sci. Nutr. 2014, 54, 790–806. [Google Scholar] [CrossRef] [PubMed]
  16. Libby, P.; Aikawa, M.; Jain, M.K. Vascular endothelium and atherosclerosis. Hand. Exp. Pharmacol. 2006, 176, 285–306. [Google Scholar]
  17. Zhu, Y.; Ling, W.; Guo, H.; Song, F.; Ye, Q.; Zou, T.; Li, D.; Zhang, Y.; Li, G.; Xiao, Y.; et al. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: A randomized controlled trial. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 843–849. [Google Scholar] [CrossRef]
  18. Riso, P.; Klimis-Zacas, D.; Del Bo’, C.; Martini, D.; Campolo, J.; Vendrame, S.; Møller, P.; Loft, S.; De Maria, R.; Porrini, M. Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors. Eur. J. Nutr. 2012, 52, 949–961. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Basu, A.; Lyons, T.J. Strawberries, Blueberries, and Cranberries in the Metabolic Syndrome: Clinical Perspectives. J. Agric. Food Chem. 2011, 60, 5687–5692. [Google Scholar] [CrossRef]
  20. Basu, A.; Morris, S.; Nguyen, A.; Betts, N.M.; Fu, D.; Lyons, T.J. Effects of Dietary Strawberry Supplementation on Antioxidant Biomarkers in Obese Adults with Above Optimal Serum Lipids. J. Nutr. Metab. 2016, 2016, 3910630. [Google Scholar] [CrossRef] [Green Version]
  21. Basu, A.; Du, M.; Leyva, M.J.; Sanchez, K.; Betts, N.M.; Wu, M.; Aston, C.E.; Lyons, T.J. Blueberries Decrease Cardiovascular Risk Factors in Obese Men and Women with Metabolic Syndrome. J. Nutr. 2010, 140, 1582–1587. [Google Scholar] [CrossRef] [Green Version]
  22. Basu, A.; Betts, N.M.; Mulugeta, A.; Tong, C.; Newman, E.; Lyons, T.J. Green tea supplementation increases glutathione and plasma antioxidant capacity in adults with the metabolic syndrome. Nutr. Res. 2013, 33, 180–187. [Google Scholar] [CrossRef] [Green Version]
  23. Basu, A.; Izuora, K.; Betts, N.; Kinney, J.; Salazar, A.; Ebersole, J.; Scofield, R. Dietary Strawberries Improve Cardiometabolic Risks in Adults with Obesity and Elevated Serum LDL Cholesterol in a Randomized Controlled Crossover Trial. Nutrients 2021, 13, 1421. [Google Scholar] [CrossRef] [PubMed]
  24. Beutler, E.; Duron, O.; Kelly, B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 1963, 61, 882–888. [Google Scholar]
  25. Miller, N.J.; Rice-Evans, C.; Davies, M.; Gopinathan, V.; Milner, A. A Novel Method for Measuring Antioxidant Capacity and its Application to Monitoring the Antioxidant Status in Premature Neonates. Clin. Sci. 1993, 84, 407–412. [Google Scholar] [CrossRef] [Green Version]
  26. Jain, S.K.; McVie, R.; Duett, J.; Herbst, J.J. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989, 38, 1539–1543. [Google Scholar] [CrossRef]
  27. Henning, S.M.; Seeram, N.P.; Zhang, Y.; Li, L.; Gao, K.; Lee, R.-P.; Wang, D.C.; Zerlin, A.; Karp, H.; Thames, G.; et al. Strawberry Consumption Is Associated with Increased Antioxidant Capacity in Serum. J. Med. Food 2010, 13, 116–122. [Google Scholar] [CrossRef] [PubMed]
  28. Cao, G.; Russell, R.M.; Lischner, N.; Prior, R.L. Serum Antioxidant Capacity Is Increased by Consumption of Strawberries, Spinach, Red Wine or Vitamin C in Elderly Women. J. Nutr. 1998, 128, 2383–2390. [Google Scholar] [CrossRef] [PubMed]
  29. Tulipani, S.; Alvarez-Suarez, J.M.; Busco, F.; Bompadre, S.; Quiles, J.L.; Mezzetti, B.; Battino, M. Strawberry consumption improves plasma antioxidant status and erythrocyte resistance to oxidative haemolysis in humans. Food Chem. 2011, 128, 180–186. [Google Scholar] [CrossRef] [PubMed]
  30. Panahi, Y.; Hosseini, M.S.; Khalili, N.; Naeimi, E.; Majeed, M.; Sahebkar, A. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin. Nutr. 2015, 34, 1101–1108. [Google Scholar] [CrossRef] [PubMed]
  31. Estruch, R.; Sacanella, E.; Mota, F.; Chiva-Blanch, G.; Antúnez, E.; Casals, E.; Deulofeu, R.; Rotilio, D.; Andres-Lacueva, C.; Lamuela-Raventos, R.M. Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dismutase activity: A randomised cross-over trial. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 46–53. [Google Scholar] [CrossRef] [PubMed]
  32. Sarkhosh-Khorasani, S.; Sangsefidi, Z.S.; Hosseinzadeh, M. The effect of grape products containing polyphenols on oxidative stress: A systematic review and meta-analysis of randomized clinical trials. Nutr. J. 2021, 20, 1–18. [Google Scholar] [CrossRef] [PubMed]
  33. de Liz, S.; Cardoso, A.L.; Copetti, C.L.K.; de Fragas Highin, P.; Vieria, F.G.K.; de Silva, E.L.; Schulz, M.; Fett, R.; Mikke, G.A.; Di Pietro, P.F. Açaí (Euterpe oleracea Mart.) and juçara (Euterpe edulis Mart.) juices improved HDL-c levels and antioxidant defense of healthy adults in a 4-week randomized cross-over study. Clin. Nutr. 2020, 39, 3629–3636. [Google Scholar] [CrossRef] [PubMed]
  34. Basu, A.; Fu, D.X.; Wilkinson, M.; Simmons, B.; Wu, M.; Betts, N.M.; Du, M.; Lyons, T.J. Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr. Res. 2010, 30, 462–469. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Schell, J.; Scofield, R.H.; Barrett, J.R.; Kurien, B.T.; Betts, N.; Lyons, T.J.; Zhao, Y.D.; Basu, A. Strawberries Improve Pain and Inflammation in Obese Adults with Radiographic Evidence of Knee Osteoarthritis. Nutrients 2017, 9, 949. [Google Scholar] [CrossRef]
  36. Stote, K.S.; Sweeney, M.I.; Kean, T.; Baer, D.J.; Novotny, J.A.; Shakerley, N.; Chandrasekaran, A.; Carrico, P.M.; Melendez, J.A.; Gottschall-Pass, K.T. The effects of 100% wild blueberry (Vaccinium angustifolium) juice consumption on cardiometablic biomarkers: A randomized, placebo-controlled, crossover trial in adults with increased risk for type 2 diabetes. BMC Nutr. 2017, 3, 45. [Google Scholar] [CrossRef]
  37. Guo, W.; Kim, S.H.; Wu, D.; Li, L.; Ortega, E.F.; Thomas, M.; Meydani, S.N.; Meydani, M. Dietary Fruit and Vegetable Supplementation Suppresses Diet-Induced Atherosclerosis in LDL Receptor Knockout Mice. J. Nutr. 2021, 151, 902–910. [Google Scholar] [CrossRef]
  38. Iwashima, T.; Kudome, Y.; Kishimoto, Y.; Saita, E.; Tanaka, M.; Taguchi, C.; Hirakawa, S.; Mitani, N.; Kondo, K.; Iida, K. Aronia berry extract inhibits TNF-α-induced vascular endothelial inflammation through the regulation of STAT3. Food Nutr. Res. 2019, 63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Di Pietro, N.; Baldassarre, M.P.A.; Cichelli, A.; Pandolfi, A.; Formoso, G.; Pipino, C. Role of Polyphenols and Carotenoids in Endothelial Dysfunction: An Overview from Classic to Innovative Biomarkers. Oxid. Med. Cell. Longev. 2020, 2020, 6381380. [Google Scholar] [CrossRef]
  40. Yubero-Serrano, E.M.; Delgado-Lista, J.; Peña-Orihuela, P.; Martínez, P.P.; Fuentes, F.; Marin, C.; Tunez, I.; Tinahones, F.J.; Perez-Jimenez, F.; Roche, H.; et al. Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Exp. Mol. Med. 2013, 45, e28. [Google Scholar] [CrossRef] [Green Version]
  41. Baez-Duarte, B.G.; Zamora-Ginez, I.; De Jésus, K.L.; Torres-Rasgado, E.; Gonzalez-Mejia, M.E.; Porchia, L.M.; Ruiz-Vivanco, G.; Pérez-Fuentes, R. Association of the Metabolic Syndrome with Antioxidant Defense and Outstanding Superoxide Dismutase Activity in Mexican Subjects. Metab. Syndr. Relat. Disord. 2016, 14, 154–160. [Google Scholar] [CrossRef] [PubMed]
  42. Yadav, D.; Mishra, M.; Joseph, A.Z.; Subramani, S.K.; Mahajan, S.; Singh, N.; Bisen, P.S.; Prasad, G. Status of antioxidant and lipid peroxidation in type 2 diabetic human subjects diagnosed with and without metabolic syndrome by using NCEP-ATPIII, IDF and WHO criteria. Obes. Res. Clin. Pract. 2015, 9, 158–167. [Google Scholar] [CrossRef] [PubMed]
Table
Table 1. Serum antioxidants and oxidative stress biomarkers in adults with the metabolic syndrome following control, low, and high-dose strawberry powder for a period of four weeks each in a randomized crossover study.
Table 1. Serum antioxidants and oxidative stress biomarkers in adults with the metabolic syndrome following control, low, and high-dose strawberry powder for a period of four weeks each in a randomized crossover study.
VariableBaselineControl
(4-Week)		Strawberry
(LD) (4-Week)		Strawberry
(HD) (4-Week)		p-Value 1
(Treatment)
Serum catalase, U/mL 255 ± 1464 ± 1174 ± 1767 ± 90.25
Serum glutathione, µM1021 ± 420997 ± 3121121 ± 3321143 ± 4120.05
Serum GR, nmol/min/mL56 ± 1452 ± 1662 ± 1863 ± 120.28
Serum GPX, mU/mL22 ± 1125 ± 933 ± 829 ± 100.34
Serum SOD, U/mL0.02 ± 0.01 a0.03 ± 0.02 a0.04 ± 0.02 b0.06 ± 0.04 b0.02
Serum nitrite, µM32 ± 1926 ± 823 ± 1125 ± 150.28
Serum antioxidant capacity, µmol/L5.2 ± 4.3 a4.9 ± 4.2 a6.5 ± 4.5 b7.3 ± 3.5 b0.02
Serum MDA, nmol/mL5.16 ± 2.06 b4.86 ± 3.21 a3.50 ± 2.06 b3.21 ± 1.31 b0.002
Data presented as means ± SD. N = 33/group. HD = High dose (~2.5 servings of strawberries/day); LD = low dose (~1.0 serving of strawberries/day). GR = glutathione reductase; GPX = glutathione peroxidase; MDA = malondialdehyde; SOD = superoxide dismutase. 1 P for main effect of treatment from a mixed model ANOVA. Repeated measures adjusted for baseline values. a,b Different superscripts indicate significantly different values. p < 0.05 in bold font. 2 P for significant time effect with higher values at 14 weeks compared to baseline and four weeks (p < 0.05).
Table
Table 2. Serum biomarkers of endothelial dysfunction and inflammation in adults with the metabolic syndrome following control, low, and high-dose strawberries for a period of four weeks each in a randomized crossover study.
Table 2. Serum biomarkers of endothelial dysfunction and inflammation in adults with the metabolic syndrome following control, low, and high-dose strawberries for a period of four weeks each in a randomized crossover study.
VariableBaselineControl
(4-Week)		Strawberry
(LD) (4-Week)		Strawberry
(HD) (4-Week)		p-Value 1
(Treatment)
Serum sICAM-1, ng/mL321 ± 109333 ± 113305 ± 95311 ± 990.34
Serum sVCAM-1, ng/mL288 ± 114 a279 ± 103 a262 ± 102 a231 ± 98 b0.02
Serum sP-selectin, ng/mL118 ± 65124 ± 77108 ± 75111 ± 550.26
Serum sE-selectin, ng/mL37.4 ± 12.532.1 ± 10.528.6 ± 9.531.6 ± 11.50.21
Serum IL-6, pg/mL7.6 ± 4.46.8 ± 5.17.2 ± 6.46.3 ± 3.40.17
Serum IL-1β, pg/mL12.7 ± 5.811.4 ± 6.410.7 ± 5.313.4 ± 6.50.19
Serum TNF-α, pg/mL6.3 ± 3.5 a5.7 ± 4.5 a4.5 ± 3.2 a3.8 ± 3.6 b0.01
Data presented as means ± SD. N = 33/group. HD = High dose (~2.5 servings of strawberries/day); LD = low dose (~1.0 serving of strawberries/day); IL-6 = interleukin-6; IL-1β = interleuin-1beta; sICAM-1 = soluble intercellular adhesion molecule-1; sVCAM-1 = soluble vascular cell adhesion molecule-1; TNF-α = tumor necrosis factor alpha. 1 P for main effect of treatment from a mixed model ANOVA. Repeated measures adjusted for baseline values. a,b Different superscripts indicate significantly different values. p < 0.05 in bold font.
Table
Table 3. Partial correlation coefficients among serum antioxidants, lipid oxidation, and inflammatory biomarkers adjusted for age and BMI at baseline and at the end of the study.
Table 3. Partial correlation coefficients among serum antioxidants, lipid oxidation, and inflammatory biomarkers adjusted for age and BMI at baseline and at the end of the study.
Variable by TimesICAM-1sVCAM-1IL-1βTNF-α
Glutathione
Baseline
End		0.21
0.15		−0.42
−0.35		0.14
0.08		−0.12
−0.09
SOD
Baseline
End		−0.05
−0.06		−0.18
−0.23		−0.02
−0.02		−0.23
−0.19
Antioxidant capacity
Baseline
End		0.08
0.11		−0.25
−0.32		−0.05
−0.05		−0.03
−0.02
MDA
Baseline
End		0.07
0.05		0.13
0.15		0.03
0.02		0.28
0.35
N = 33 at baseline and end of study. Abbreviations: BMI = body mass index; MDA = malondialdehyde; SOD = superoxide dismutase; IL−1β = interleuin-1beta; sICAM-1 = soluble intercellular adhesion molecule-1; sVCAM-1 = soluble vascular cell adhesion molecule-1; TNF-α = tumor necrosis factor alpha. p < 0.05 in bold font.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Basu, A.; Izuora, K.; Betts, N.M.; Ebersole, J.L.; Scofield, R.H. Dietary Strawberries Improve Biomarkers of Antioxidant Status and Endothelial Function in Adults with Cardiometabolic Risks in a Randomized Controlled Crossover Trial. Antioxidants 2021, 10, 1730. https://doi.org/10.3390/antiox10111730

AMA Style

Basu A, Izuora K, Betts NM, Ebersole JL, Scofield RH. Dietary Strawberries Improve Biomarkers of Antioxidant Status and Endothelial Function in Adults with Cardiometabolic Risks in a Randomized Controlled Crossover Trial. Antioxidants. 2021; 10(11):1730. https://doi.org/10.3390/antiox10111730

Chicago/Turabian Style

Basu, Arpita, Kenneth Izuora, Nancy M. Betts, Jeffrey L. Ebersole, and Robert Hal Scofield. 2021. "Dietary Strawberries Improve Biomarkers of Antioxidant Status and Endothelial Function in Adults with Cardiometabolic Risks in a Randomized Controlled Crossover Trial" Antioxidants 10, no. 11: 1730. https://doi.org/10.3390/antiox10111730

APA Style

Basu, A., Izuora, K., Betts, N. M., Ebersole, J. L., & Scofield, R. H. (2021). Dietary Strawberries Improve Biomarkers of Antioxidant Status and Endothelial Function in Adults with Cardiometabolic Risks in a Randomized Controlled Crossover Trial. Antioxidants, 10(11), 1730. https://doi.org/10.3390/antiox10111730

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop